228 related articles for article (PubMed ID: 38104183)
21. Fra-2/AP-1 regulates melanoma cell metastasis by downregulating Fam212b.
Chen GL; Li R; Chen XX; Wang J; Cao S; Song R; Zhao MC; Li LM; Hannemmann N; Schett G; Qian C; Bozec A
Cell Death Differ; 2021 Apr; 28(4):1364-1378. PubMed ID: 33188281
[TBL] [Abstract][Full Text] [Related]
22. Attenuated expression of the serum responsive T1 gene in ras transformed fibroblasts due to the inhibition of c-fos gene activity.
Kessler R; Zacharova-Albinger A; Laursen NB; Kalousek M; Klemenz R
Oncogene; 1999 Mar; 18(9):1733-44. PubMed ID: 10208434
[TBL] [Abstract][Full Text] [Related]
23. c-Jun, Fra-2, and ATF-2 immunoreactivity in the jejunal tissues of the healthy rat.
Keklikoglu N
Dig Dis Sci; 2008 Oct; 53(10):2680-6. PubMed ID: 18320311
[TBL] [Abstract][Full Text] [Related]
24. Expression and distribution of AP-1 transcription factors in the porcine ovary.
Rusovici R; LaVoie HA
Biol Reprod; 2003 Jul; 69(1):64-74. PubMed ID: 12606371
[TBL] [Abstract][Full Text] [Related]
25. Expression of activator protein-1 (AP-1) family members in breast cancer.
Kharman-Biz A; Gao H; Ghiasvand R; Zhao C; Zendehdel K; Dahlman-Wright K
BMC Cancer; 2013 Sep; 13():441. PubMed ID: 24073962
[TBL] [Abstract][Full Text] [Related]
26. High levels of phosphorylated c-Jun, Fra-1, Fra-2 and ATF-2 proteins correlate with malignant phenotypes in the multistage mouse skin carcinogenesis model.
Zoumpourlis V; Papassava P; Linardopoulos S; Gillespie D; Balmain A; Pintzas A
Oncogene; 2000 Aug; 19(35):4011-21. PubMed ID: 10962557
[TBL] [Abstract][Full Text] [Related]
27. Mitogen activated protein kinase-dependent activation of c-Jun and c-Fos is required for neuronal differentiation but not for growth and stress response in PC12 cells.
Eriksson M; Taskinen M; Leppä S
J Cell Physiol; 2007 Feb; 210(2):538-48. PubMed ID: 17111371
[TBL] [Abstract][Full Text] [Related]
28. Conversion of HPV 18 positive non-tumorigenic HeLa-fibroblast hybrids to invasive growth involves loss of TNF-alpha mediated repression of viral transcription and modification of the AP-1 transcription complex.
Soto U; Das BC; Lengert M; Finzer P; zur Hausen H; Rösl F
Oncogene; 1999 May; 18(21):3187-98. PubMed ID: 10359524
[TBL] [Abstract][Full Text] [Related]
29. The requirement for and changing composition of the activating protein-1 transcription factor during differentiation of human leukemia HL60 cells induced by 1,25-dihydroxyvitamin D3.
Wang X; Studzinski GP
Cancer Res; 2006 Apr; 66(8):4402-9. PubMed ID: 16618766
[TBL] [Abstract][Full Text] [Related]
30. Antitumor promotion by phenolic antioxidants: inhibition of AP-1 activity through induction of Fra expression.
Yoshioka K; Deng T; Cavigelli M; Karin M
Proc Natl Acad Sci U S A; 1995 May; 92(11):4972-6. PubMed ID: 7761434
[TBL] [Abstract][Full Text] [Related]
31. p73 supports cellular growth through c-Jun-dependent AP-1 transactivation.
Vikhanskaya F; Toh WH; Dulloo I; Wu Q; Boominathan L; Ng HH; Vousden KH; Sabapathy K
Nat Cell Biol; 2007 Jun; 9(6):698-705. PubMed ID: 17496887
[TBL] [Abstract][Full Text] [Related]
32. Differential expression of the fos and jun family members c-fos, fosB, Fra-1, Fra-2, c-jun, junB and junD during human epidermal keratinocyte differentiation.
Welter JF; Eckert RL
Oncogene; 1995 Dec; 11(12):2681-7. PubMed ID: 8545126
[TBL] [Abstract][Full Text] [Related]
33. Transactivation of Fra-1 and consequent activation of AP-1 occur extracellular signal-regulated kinase dependently.
Young MR; Nair R; Bucheimer N; Tulsian P; Brown N; Chapp C; Hsu TC; Colburn NH
Mol Cell Biol; 2002 Jan; 22(2):587-98. PubMed ID: 11756554
[TBL] [Abstract][Full Text] [Related]
34. Fra-1 regulates its target genes via binding to remote enhancers without exerting major control on chromatin architecture in triple negative breast cancers.
Bejjani F; Tolza C; Boulanger M; Downes D; Romero R; Maqbool MA; Zine El Aabidine A; Andrau JC; Lebre S; Brehelin L; Parrinello H; Rohmer M; Kaoma T; Vallar L; Hughes JR; Zibara K; Lecellier CH; Piechaczyk M; Jariel-Encontre I
Nucleic Acids Res; 2021 Mar; 49(5):2488-2508. PubMed ID: 33533919
[TBL] [Abstract][Full Text] [Related]
35. Role of AP-1 family proteins in regulation of inducible nitric oxide synthase (iNOS) in human neutrophils.
Ratajczak-Wrona W; Jablonska E; Garley M; Jablonski J; Radziwon P; Iwaniuk A
J Immunotoxicol; 2013; 10(1):32-9. PubMed ID: 22734893
[TBL] [Abstract][Full Text] [Related]
36. Role of the Fos family members, c-Fos, Fra-1 and Fra-2, in the regulation of cell motility.
Tkach V; Tulchinsky E; Lukanidin E; Vinson C; Bock E; Berezin V
Oncogene; 2003 Aug; 22(32):5045-54. PubMed ID: 12902987
[TBL] [Abstract][Full Text] [Related]
37. AP-1 transrepressing retinoic acid does not deplete coactivators or AP-1 monomers but may target specific Jun or Fos containing dimers.
Suzukawa K; Colburn NH
Oncogene; 2002 Mar; 21(14):2181-90. PubMed ID: 11948401
[TBL] [Abstract][Full Text] [Related]
38. Elevated ERK-MAP kinase activity protects the FOS family member FRA-1 against proteasomal degradation in colon carcinoma cells.
Vial E; Marshall CJ
J Cell Sci; 2003 Dec; 116(Pt 24):4957-63. PubMed ID: 14625389
[TBL] [Abstract][Full Text] [Related]
39. Common and distinct mechanisms of different redox-active carcinogens involved in the transformation of mouse JB6P+ cells.
Yang S; Misner B; Chiu R; Meyskens FL
Mol Carcinog; 2008 Jul; 47(7):485-91. PubMed ID: 18092320
[TBL] [Abstract][Full Text] [Related]
40. fra-2 promoter can respond to serum-stimulation through AP-1 complexes.
Sonobe MH; Yoshida T; Murakami M; Kameda T; Iba H
Oncogene; 1995 Feb; 10(4):689-96. PubMed ID: 7862446
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
